<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Saudi Med J</journal-id><journal-id journal-id-type="iso-abbrev">Saudi Med J</journal-id><journal-id journal-id-type="publisher-id">SaudiMedJ</journal-id><journal-title-group><journal-title>Saudi Medical Journal</journal-title></journal-title-group><issn pub-type="ppub">0379-5284</issn><issn pub-type="epub">1658-3175</issn><publisher><publisher-name>Saudi Medical Journal</publisher-name><publisher-loc>Saudi Arabia</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25316464</article-id><article-id pub-id-type="pmc">4362117</article-id><article-id pub-id-type="publisher-id">SaudiMedJ-35-1203</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Evaluation of adjunctive systemic doxycycline with non-surgical periodontal therapy within type 2 diabetic patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Al-Nowaiser</surname><given-names>Abeer M.</given-names></name><degrees>MPHE, PhD</degrees><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Al-Zoman</surname><given-names>Hamad</given-names></name><degrees>BDS, MDSc</degrees><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Baskaradoss</surname><given-names>Jagan K.</given-names></name><degrees>BDS, MPH</degrees><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Robert</surname><given-names>Asirvatham A.</given-names></name><degrees>MSc, Mphil</degrees><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Al-Zoman</surname><given-names>Khalid H.</given-names></name><degrees>BDS, MSc</degrees><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Al-Sohail</surname><given-names>Abdulaziz M.</given-names></name><degrees>BDS, MSc</degrees><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Al-Suwyed</surname><given-names>Abdulaziz S.</given-names></name><degrees>BDS, MSc</degrees><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Ciancio</surname><given-names>Sebastian G.</given-names></name><degrees>DDS</degrees><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Al-Mubarak</surname><given-names>Sultan A.</given-names></name><degrees>MDSc, PhD</degrees><xref ref-type="aff" rid="aff1"></xref><xref ref-type="corresp" rid="cor1"></xref></contrib></contrib-group><aff id="aff1"><italic>From the Department of Preventive Dental Sciences (Al-Nowaiser), King Abdulaziz University, College of Dentistry (Al-Zoman H), King Saud University, the Department of Endocrinology and Diabetes (Robert), Diabetes Treatment Center, Prince Sultan Military Medical City, the Dental Department (Al-Zoman K, Al-Mubarak), King Faisal Specialist Hospital &amp; Research Center, the Prince Abdulrahman Bin Abdulaziz Institute for Higher Dental Studies (Al-Sohail), the Dental Department (Al-Suwyed), King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Dental Public Health (Baskaradoss), School of Dental Medicine, Case Western Reserve University, Cleveland, Ohio, and the Department of Periodontics and Endodontics (Ciancio), School of Dental Medicine, State University of New York at Buffalo, Buffalo, New York, United States of America.</italic></aff><author-notes><corresp id="cor1"><italic>Address correspondence and reprint request to: Dr. Sultan A. Al-Mubarak, Senior Clinical Scientist and Consultant, Dental Department, King Faisal Specialist Hospital &amp; Research Center, PO Box 3354, Riyadh 11211, Kingdom of Saudi Arabia. E-mail: salmubarak@kfshrc.edu.sa</italic></corresp></author-notes><pub-date pub-type="ppub"><year>2014</year></pub-date><volume>35</volume><issue>10</issue><fpage>1203</fpage><lpage>1209</lpage><history><date date-type="received"><day>22</day><month>4</month><year>2014</year></date><date date-type="accepted"><day>16</day><month>7</month><year>2014</year></date></history><permissions><copyright-statement>Copyright: Â© Saudi Medical Journal</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="4973" xml_f="4984" txt_i="11" txt_f="22">Objectives:</offsets></title><p><offsets xml_i="4995" xml_f="5134" txt_i="23" txt_f="162">To evaluate the effects of systemic doxycycline on clinical and microbiological parameters of diabetic subjects with chronic periodontitis.</offsets></p></sec><sec id="st2"><title><offsets xml_i="5165" xml_f="5173" txt_i="164" txt_f="172">Methods:</offsets></title><p><offsets xml_i="5184" xml_f="5903" txt_i="173" txt_f="892">This 9-month multi-center, randomized, parallel, single-blinded study was conducted from different hospitals in Riyadh, Saudi Arabia between April 2010 and December 2010. A total of 76 diabetic subjects with chronic periodontitis were randomized into 2 groups: control group (CG) received only scaling and root planing (SRP), and the treatment group (TG) receiving systemic doxycycline during the reevaluation visit 45 days after the completion of SRP. Probing pocket depth, clinical attachment level, gingival index, plaque index, and bleeding on probing were collected at baseline, 45 days after SRP, and one, 3, and 6 months after the use of systemic doxycycline. Microbiological analysis comprised the detection of </offsets><italic><offsets xml_i="5911" xml_f="5931" txt_i="892" txt_f="912">Tannerella forsythia</offsets></italic><offsets xml_i="5940" xml_f="5942" txt_i="912" txt_f="914"> (</offsets><italic><offsets xml_i="5950" xml_f="5952" txt_i="914" txt_f="916">Tf</offsets></italic><offsets xml_i="5961" xml_f="5964" txt_i="916" txt_f="919">), </offsets><italic><offsets xml_i="5972" xml_f="6009" txt_i="919" txt_f="956">Aggregatibacter actinomycetemcomitans</offsets></italic><offsets xml_i="6018" xml_f="6020" txt_i="956" txt_f="958"> (</offsets><italic><offsets xml_i="6028" xml_f="6030" txt_i="958" txt_f="960">Aa</offsets></italic><offsets xml_i="6039" xml_f="6042" txt_i="960" txt_f="963">), </offsets><italic><offsets xml_i="6050" xml_f="6074" txt_i="963" txt_f="987">Porphyromonas gingivalis</offsets></italic><offsets xml_i="6083" xml_f="6085" txt_i="987" txt_f="989"> (</offsets><italic><offsets xml_i="6093" xml_f="6095" txt_i="989" txt_f="991">Pg</offsets></italic><offsets xml_i="6104" xml_f="6111" txt_i="991" txt_f="998">), and </offsets><italic><offsets xml_i="6119" xml_f="6140" txt_i="998" txt_f="1019">Prevotella intermedia</offsets></italic><offsets xml_i="6149" xml_f="6151" txt_i="1019" txt_f="1021"> (</offsets><italic><offsets xml_i="6159" xml_f="6161" txt_i="1021" txt_f="1023">Pi</offsets></italic><offsets xml_i="6170" xml_f="6208" txt_i="1023" txt_f="1061">) by polymerase chain reaction method.</offsets></p></sec><sec id="st3"><title><offsets xml_i="6239" xml_f="6247" txt_i="1063" txt_f="1071">Results:</offsets></title><p><offsets xml_i="6258" xml_f="6357" txt_i="1072" txt_f="1171">Sixty-eight (33 CG and 35 TG) subjects completed the study. Greater reduction in the population of </offsets><italic><offsets xml_i="6365" xml_f="6371" txt_i="1171" txt_f="1177">Tf, Pg</offsets></italic><offsets xml_i="6380" xml_f="6386" txt_i="1177" txt_f="1183">, and </offsets><italic><offsets xml_i="6394" xml_f="6396" txt_i="1183" txt_f="1185">Pi</offsets></italic><offsets xml_i="6405" xml_f="6599" txt_i="1185" txt_f="1379"> were observed in TG compared with CG in the first month after the administration of systemic doxycycline. The TG showed a significant improvement in gingival index scores compared with the CG (</offsets><italic><offsets xml_i="6607" xml_f="6608" txt_i="1379" txt_f="1380">p</offsets></italic><offsets xml_i="6617" xml_f="6704" txt_i="1380" txt_f="1464">&lt;0.05) by the end of the first and 6 months after the administration of doxycycline.</offsets></p></sec><sec id="st4"><title><offsets xml_i="6735" xml_f="6746" txt_i="1466" txt_f="1477">Conclusion:</offsets></title><p><offsets xml_i="6757" xml_f="6824" txt_i="1478" txt_f="1545">Adjunct systemic doxycycline can be associated with a reduction of </offsets><italic><offsets xml_i="6832" xml_f="6838" txt_i="1545" txt_f="1551">Tf, Pg</offsets></italic><offsets xml_i="6847" xml_f="6853" txt_i="1551" txt_f="1557">, and </offsets><italic><offsets xml_i="6861" xml_f="6863" txt_i="1557" txt_f="1559">Pi</offsets></italic><offsets xml_i="6872" xml_f="6962" txt_i="1559" txt_f="1649"> in the first month after the administration of doxycycline with an improvement in the GI.</offsets></p></sec></abstract></article-meta></front><body><p><offsets xml_i="7015" xml_f="7097" txt_i="1658" txt_f="1740">The relationship between periodontal diseases (PD) and diabetes are bidirectional,</offsets><xref rid="ref1" ref-type="bibr"><offsets xml_i="7130" xml_f="7131" txt_i="1740" txt_f="1741">1</offsets></xref><offsets xml_i="7138" xml_f="7278" txt_i="1741" txt_f="1881"> which provides an example of systemic disease predisposing to oral infection, established infection, and exacerbating the systemic disease.</offsets><xref rid="ref2" ref-type="bibr"><offsets xml_i="7311" xml_f="7312" txt_i="1881" txt_f="1882">2</offsets></xref><offsets xml_i="7319" xml_f="7389" txt_i="1882" txt_f="1952"> Diabetic patients are known to be susceptible to infectious diseases.</offsets><xref rid="ref3" ref-type="bibr"><offsets xml_i="7422" xml_f="7423" txt_i="1952" txt_f="1953">3</offsets></xref><offsets xml_i="7430" xml_f="7516" txt_i="1953" txt_f="2039"> The influence of diabetes on the onset and development of PD has been widely studied.</offsets><xref rid="ref4" ref-type="bibr"><offsets xml_i="7549" xml_f="7550" txt_i="2039" txt_f="2040">4</offsets></xref><offsets xml_i="7557" xml_f="7558" txt_i="2040" txt_f="2041">,</offsets><xref rid="ref5" ref-type="bibr"><offsets xml_i="7591" xml_f="7592" txt_i="2041" txt_f="2042">5</offsets></xref><offsets xml_i="7599" xml_f="7669" txt_i="2042" txt_f="2112"> The PD is now considered the sixth complication of diabetes mellitus.</offsets><xref rid="ref6" ref-type="bibr"><offsets xml_i="7702" xml_f="7703" txt_i="2112" txt_f="2113">6</offsets></xref><offsets xml_i="7710" xml_f="7711" txt_i="2113" txt_f="2114">,</offsets><xref rid="ref7" ref-type="bibr"><offsets xml_i="7744" xml_f="7745" txt_i="2114" txt_f="2115">7</offsets></xref><offsets xml_i="7752" xml_f="7933" txt_i="2115" txt_f="2296"> Diabetes in itself does not cause PD, but it makes the patients more susceptible to periodontal destruction. Diabetics exhibit greater severity and a faster rate of PD progression.</offsets><xref rid="ref8" ref-type="bibr"><offsets xml_i="7966" xml_f="7967" txt_i="2296" txt_f="2297">8</offsets></xref><offsets xml_i="7974" xml_f="7975" txt_i="2297" txt_f="2298">,</offsets><xref rid="ref9" ref-type="bibr"><offsets xml_i="8008" xml_f="8009" txt_i="2298" txt_f="2299">9</offsets></xref><offsets xml_i="8016" xml_f="8328" txt_i="2299" txt_f="2611"> Treating chronic periodontitis in diabetic patients poses numerous challenges, especially with regards to the control of oral microorganisms. Treatment of PD is directed to the elimination of sub-gingival bacterial infections. More than 700 different bacterial species are found in the sub-gingival environment.</offsets><xref rid="ref10" ref-type="bibr"><offsets xml_i="8362" xml_f="8364" txt_i="2611" txt_f="2613">10</offsets></xref><offsets xml_i="8371" xml_f="8491" txt_i="2613" txt_f="2733"> Several studies have reported that the bacteria involved in periodontitis are usually anaerobic Gram-negative bacteria.</offsets><xref rid="ref11" ref-type="bibr"><offsets xml_i="8525" xml_f="8527" txt_i="2733" txt_f="2735">11</offsets></xref><offsets xml_i="8534" xml_f="8535" txt_i="2735" txt_f="2736">
</offsets><italic><offsets xml_i="8543" xml_f="8580" txt_i="2736" txt_f="2773">Aggregatibacter actinomycetemcomitans</offsets></italic><offsets xml_i="8589" xml_f="8591" txt_i="2773" txt_f="2775"> (</offsets><italic><offsets xml_i="8599" xml_f="8601" txt_i="2775" txt_f="2777">Aa</offsets></italic><offsets xml_i="8610" xml_f="8613" txt_i="2777" txt_f="2780">), </offsets><italic><offsets xml_i="8621" xml_f="8641" txt_i="2780" txt_f="2800">Tannerella forsythia</offsets></italic><offsets xml_i="8650" xml_f="8652" txt_i="2800" txt_f="2802"> (</offsets><italic><offsets xml_i="8660" xml_f="8662" txt_i="2802" txt_f="2804">Tf</offsets></italic><offsets xml_i="8671" xml_f="8678" txt_i="2804" txt_f="2811">), and </offsets><italic><offsets xml_i="8686" xml_f="8710" txt_i="2811" txt_f="2835">Porphyromonas gingivalis</offsets></italic><offsets xml_i="8719" xml_f="8721" txt_i="2835" txt_f="2837"> (</offsets><italic><offsets xml_i="8729" xml_f="8731" txt_i="2837" txt_f="2839">Pg</offsets></italic><offsets xml_i="8740" xml_f="8916" txt_i="2839" txt_f="3015">) were directly implicated in the destruction of periodontal tissues, and the presence of any of these pathogens is considered a risk factor for future periodontal destruction.</offsets><xref rid="ref12" ref-type="bibr"><offsets xml_i="8950" xml_f="8952" txt_i="3015" txt_f="3017">12</offsets></xref><offsets xml_i="8959" xml_f="9171" txt_i="3017" txt_f="3229"> Direct and indirect damage to periodontal supporting tissues are well-documented pathogenic effects of Gram-negative bacteria due to their toxic products and the activation of a series of inflammatory reactions.</offsets><xref rid="ref13" ref-type="bibr"><offsets xml_i="9205" xml_f="9207" txt_i="3229" txt_f="3231">13</offsets></xref><offsets xml_i="9214" xml_f="9439" txt_i="3231" txt_f="3456"> Mechanical means using non-surgical and surgical techniques is the primary approach employed in the treatment of PD. Subgingival scaling and root planning (SRP) is an effective method to slow or arrest the progression of PD.</offsets><xref rid="ref14" ref-type="bibr"><offsets xml_i="9473" xml_f="9475" txt_i="3456" txt_f="3458">14</offsets></xref><offsets xml_i="9482" xml_f="9483" txt_i="3458" txt_f="3459">,</offsets><xref rid="ref15" ref-type="bibr"><offsets xml_i="9517" xml_f="9519" txt_i="3459" txt_f="3461">15</offsets></xref><offsets xml_i="9526" xml_f="9711" txt_i="3461" txt_f="3646"> Even after meticulous SRP, some patients may still experience continuous loss of attachment due to the inability of the therapy to suppress periodontal pathogens to the optimal levels.</offsets><xref rid="ref16" ref-type="bibr"><offsets xml_i="9745" xml_f="9747" txt_i="3646" txt_f="3648">16</offsets></xref><offsets xml_i="9754" xml_f="9759" txt_i="3648" txt_f="3653"> The </offsets><italic><offsets xml_i="9767" xml_f="9769" txt_i="3653" txt_f="3655">Aa</offsets></italic><offsets xml_i="9778" xml_f="9783" txt_i="3655" txt_f="3660"> and </offsets><italic><offsets xml_i="9791" xml_f="9793" txt_i="3660" txt_f="3662">Pg</offsets></italic><offsets xml_i="9802" xml_f="9954" txt_i="3662" txt_f="3814">, is likely to evade SRP, especially in the subgingival niche, due to limited access to the root surface and the tissue-invading skills of the bacteria.</offsets><xref rid="ref17" ref-type="bibr"><offsets xml_i="9988" xml_f="9990" txt_i="3814" txt_f="3816">17</offsets></xref><offsets xml_i="9997" xml_f="10127" txt_i="3816" txt_f="3946"> The efficacy of SRP may also be compromised by the remaining bacterial virulence factors and ineffective personal plaque control.</offsets><xref rid="ref18" ref-type="bibr"><offsets xml_i="10161" xml_f="10163" txt_i="3946" txt_f="3948">18</offsets></xref><offsets xml_i="10170" xml_f="10309" txt_i="3948" txt_f="4087"> Thus, various pharmacological agents were used as adjunctive therapy to improve the treatment outcome of non-surgical periodontal therapy.</offsets><xref rid="ref19" ref-type="bibr"><offsets xml_i="10343" xml_f="10345" txt_i="4087" txt_f="4089">19</offsets></xref><offsets xml_i="10352" xml_f="10605" txt_i="4089" txt_f="4342"> Adjunctive antimicrobials can be used for local or systemic delivery. The benefits of using various adjunctive antibiotics such as penicillin, tetracycline, amoxicillin, and metronidazole along with SRP have been reported to improve periodontal health.</offsets><xref rid="ref20" ref-type="bibr"><offsets xml_i="10639" xml_f="10641" txt_i="4342" txt_f="4344">20</offsets></xref><offsets xml_i="10648" xml_f="10649" txt_i="4344" txt_f="4345">-</offsets><xref rid="ref22" ref-type="bibr"><offsets xml_i="10683" xml_f="10685" txt_i="4345" txt_f="4347">22</offsets></xref><offsets xml_i="10692" xml_f="11057" txt_i="4347" txt_f="4712"> Studies that evaluated the antimicrobial effect of systemic doxycycline on the periodontal tissues of diabetic patients are scarce. This study aims to investigate the effect of SRP in conjunction with the administration of an antimicrobial dose of systemic doxycycline on the clinical and microbiological parameters in diabetic patients with chronic periodontitis.</offsets></p><sec sec-type="methods" id="sec1-2"><title><offsets xml_i="11104" xml_f="11111" txt_i="4713" txt_f="4720">Methods</offsets></title><p><offsets xml_i="11122" xml_f="11840" txt_i="4721" txt_f="5435">This 9-month multi-center, randomized, parallel, single-blinded study was conducted between April 2010 and December 2010 at King Faisal Specialist Hospital &amp; Research Center, King Abdulaziz Medical City, Naval Base Hospital, and Sultan Bin Abdulaziz Humanitarian City, Riyadh, Saudi Arabia. A total of 76 diabetic subjects with chronic periodontitis were included in this study. This study was conducted in accordance with the Helsinki Declaration of 1975, as revised in 2000, and the protocol of this study was approved by the research ethics committee of Sultan Bin Abdulaziz Humanitarian City, Riyadh, Saudi Arabia. Informed written consent was acquired from each subject that agreed to participate voluntarily.</offsets></p><sec id="sec2-1"><title><offsets xml_i="11868" xml_f="11884" txt_i="5436" txt_f="5452">Study population</offsets></title><p><offsets xml_i="11895" xml_f="12399" txt_i="5453" txt_f="5951">Diabetic subjects with moderate to severe chronic periodontitis were recruited into this study following a screening examination, including full mouth probing and radiographic evaluation. The inclusion criteria were as follows: age between 21 and 80 years, type 2 diabetes, diabetes diagnosed for â¥1 year, good physical condition with no additional serious medical conditions, the presence of at least 16 teeth, and a minimum of 8 sites with pocket depth of &gt;5mm and clinical attachment level &gt;5mm.</offsets></p><p><offsets xml_i="12406" xml_f="12870" txt_i="5952" txt_f="6416">Subjects were excluded if they: 1) were using any contradicted medications, 2) smoked within the past 5 years, 3) presented with compromised medical condition, 4) had been treated with SRP within 6 months of the baseline visit, 5) used antibiotics within 3 months prior to the study or 6) pregnant or breast feeding. Subjects who failed to appear at any time after the baseline visit or failed to attend the last visit (6 months) were also excluded from the study.</offsets></p><p><offsets xml_i="12877" xml_f="13353" txt_i="6417" txt_f="6893">The study included 76 diabetic patients with chronic periodontitis who were randomized by a computer-generated system into 2 groups. Of these, 38 subjects were assigned to the control group (CG), for whom only SRP would be provided. Three subjects from this group discontinued the study, and 2 were excluded due to lack of compliance with the medication use and visits. Three out of the 38 subjects assigned to the treatment group (TG) were excluded due to lack of compliance.</offsets></p></sec><sec id="sec1-3"><title><offsets xml_i="13387" xml_f="13411" txt_i="6895" txt_f="6919">Microbiological sampling</offsets></title><p><italic><offsets xml_i="13430" xml_f="13477" txt_i="6920" txt_f="6967">Bacterial examination for pathogenic anaerobes:</offsets></italic><offsets xml_i="13486" xml_f="13487" txt_i="6967" txt_f="6968">
</offsets><italic><offsets xml_i="13495" xml_f="13523" txt_i="6968" txt_f="6996">Tannerella forsythia, Aa, Pg</offsets></italic><offsets xml_i="13532" xml_f="13538" txt_i="6996" txt_f="7002">, and </offsets><italic><offsets xml_i="13546" xml_f="13566" txt_i="7002" txt_f="7022">Prevotellaintermedia</offsets></italic><offsets xml_i="13575" xml_f="13577" txt_i="7022" txt_f="7024"> (</offsets><italic><offsets xml_i="13585" xml_f="13587" txt_i="7024" txt_f="7026">Pi</offsets></italic><offsets xml_i="13596" xml_f="13939" txt_i="7026" txt_f="7369">) was performed by using the polymerase chain reaction (PCR) method. For each patient, 4 sites with pocket depths of â¥5 mm were randomly selected. The supragingival plaque was removed for the selected teeth, and the Florida probes were wiped with 70% isopropyl alcohol between measurements to reduce bacterial cross-contamination of the sites.</offsets><xref rid="ref23" ref-type="bibr"><offsets xml_i="13973" xml_f="13975" txt_i="7369" txt_f="7371">23</offsets></xref><offsets xml_i="13982" xml_f="14628" txt_i="7371" txt_f="8017"> After the clinical measurements were recorded, a subgingival plaque sample was taken from each site with separate sterile curettes. Each sample was instantly placed in a sterile micro centrifuge tube containing 0.5 ml Trisethylenediaminetetraacetic acid (EDTA [TE]) buffer (10 mM Tris hydrogen chloride [HCl] [pH 7.6], and 1 mM EDTA [pH 8.0]). For PCR analysis, 90 ml of vortex-mixed subgingival plaque was added to 10 Âµl of 10 x lysis buffer (100 mM Tris-HCl, pH 8.0, 10 mM EDTA, 10% Triton X-100), and boiled for 5 min, and 5 Âµl of this lysate was used in each PCR reaction. The species specific primers used for the PCR analyses are shown in </offsets><xref ref-type="table" rid="T1"><bold><offsets xml_i="14666" xml_f="14673" txt_i="8017" txt_f="8024">Table 1</offsets></bold></xref><offsets xml_i="14687" xml_f="15220" txt_i="8024" txt_f="8557">. The PCR amplification was carried out in a reaction volume of 25 Âµl consisting of 5 Âµl sample lysate, 20 Âµl reaction mixture containing 1 x PCR buffer (10 mM Tris-HCl, pH 8.8, 1.5 mM magnesium chloride, 50 mM potassium chloride, 0.1% Triton X-100), 2 units of Taq DNA polymerase (Amersham Pharmacia Biotech Inc, Piscataway, NJ, USA), 0.2 mM deoxynucleotide triphosphates, and 100 pmol of each primer. The PCR cycling was carried out in a DNA thermal cycler PE 480 (PerkinElmer, Covina, California, USA). The cycling conditions for </offsets><italic><offsets xml_i="15228" xml_f="15234" txt_i="8557" txt_f="8563">Tf, Aa</offsets></italic><offsets xml_i="15243" xml_f="15249" txt_i="8563" txt_f="8569">, and </offsets><italic><offsets xml_i="15257" xml_f="15259" txt_i="8569" txt_f="8571">Pg</offsets></italic><offsets xml_i="15268" xml_f="15419" txt_i="8571" txt_f="8722"> consisted of an initial denaturation for 5 min at 95Â°C, 35 amplification cycles of denaturation at 95Â°C for one minute, annealing of primers at 55Â°C (</offsets><italic><offsets xml_i="15427" xml_f="15429" txt_i="8722" txt_f="8724">Aa</offsets></italic><offsets xml_i="15438" xml_f="15452" txt_i="8724" txt_f="8738">) or at 60Â°C (</offsets><italic><offsets xml_i="15460" xml_f="15462" txt_i="8738" txt_f="8740">Tf</offsets></italic><offsets xml_i="15471" xml_f="15482" txt_i="8740" txt_f="8751">) or 70Â°C (</offsets><italic><offsets xml_i="15490" xml_f="15492" txt_i="8751" txt_f="8753">Pi</offsets></italic><offsets xml_i="15501" xml_f="15508" txt_i="8753" txt_f="8756"> &amp; </offsets><italic><offsets xml_i="15516" xml_f="15518" txt_i="8756" txt_f="8758">Pg</offsets></italic><offsets xml_i="15527" xml_f="15684" txt_i="8758" txt_f="8915">) for one minute, and primer extension at 72Â°C for one to 2 minutes, followed by a final extension step at 72Â°C for 2-10 minutes. The cycling conditions for </offsets><italic><offsets xml_i="15692" xml_f="15694" txt_i="8915" txt_f="8917">Pi</offsets></italic><offsets xml_i="15703" xml_f="15731" txt_i="8917" txt_f="8945"> were the same as those for </offsets><italic><offsets xml_i="15739" xml_f="15745" txt_i="8945" txt_f="8951">Tf, Aa</offsets></italic><offsets xml_i="15754" xml_f="15760" txt_i="8951" txt_f="8957">, and </offsets><italic><offsets xml_i="15768" xml_f="15770" txt_i="8957" txt_f="8959">Pg</offsets></italic><offsets xml_i="15779" xml_f="16451" txt_i="8959" txt_f="9631">, except if the annealing temperature was 58Â°C. The reaction products were examined immediately after completion of the PCR. Ten microliters of each reaction product was fractionated in a 1.5% agarose gel containing ethidium bromide (0.5 mg/ml) with 50 or 100 bp DNA ladder (Amersham Pharmacia Biotech Inc, Piscataway, NJ, USA) as a size marker, and visualized and photographed using a gel documentation and analysis system (Ultra-Violet Products Ltd, Cambridge, England). Samples from the same sites were collected for bacterial analysis at baseline, reevaluation visit (fourthy-fifth day after SRP), and at one, 3, and 6 months after treatment with systemic doxycycline.</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="16499" xml_f="16506" txt_i="9632" txt_f="9639">Table 1</offsets></label><caption><p><offsets xml_i="16526" xml_f="16608" txt_i="9639" txt_f="9721">Primers for polymerase chain reaction-based identification of periodontopathogens.</offsets></p></caption><graphic xlink:href="SaudiMedJ-35-1203-g001"></graphic></table-wrap></sec><sec id="sec2-4"><title><offsets xml_i="16720" xml_f="16739" txt_i="9723" txt_f="9742">Clinical procedures</offsets></title><p><offsets xml_i="16750" xml_f="17214" txt_i="9743" txt_f="10207">During the study, clinical dental examinations for all subjects were carried out in 4 study centers by 4 trained and pre-calibrated examiners (periodontists) who were supported by trained dental assistants. Probing depth (PD), clinical attachment level (CAL), plaque index (PI), gingival index (GI), and bleeding on probing (BOP) were measured on all existing teeth at the mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual, and disto-lingual areas</offsets><xref rid="ref24" ref-type="bibr"><offsets xml_i="17248" xml_f="17250" txt_i="10207" txt_f="10209">24</offsets></xref><offsets xml_i="17257" xml_f="17446" txt_i="10209" txt_f="10398"> with manual periodontal probes (Florida Probe Corporation, Gainesville, FL, USA). The CAL was calculated by adding PD with the distance between cemento-enamel junction and gingival margin.</offsets></p><p><offsets xml_i="17453" xml_f="19020" txt_i="10399" txt_f="11966">After baseline data collection, each subject received 6-8 sessions of scaling and root planing with ultrasonic and hand instrumentation until the root surface felt smooth with the tip of a metallic probe. Four trained dental hygienists at 4 centers performed the SRP. The dental hygiene aids were provided for the subjects. Written oral hygiene guidelines were given to all subjects within the different treatment groups at each session, including proper tooth brushing technique. After 45 days of completion of SRP, the patients were recalled for the reevaluation visit and the clinical measurements and sub-gingival plaque samples were taken. At this time, all individuals underwent sub-gingival debridement with an ultrasonic device to disturb the sub-gingival bio-film and allow better action of the drug. Randomization of the subjects into treatment and control groups was performed by using computer-generated random codes. Subjects belonging to the treatment group received an antimicrobial dose of systemic doxycycline, 100 mg per day for 14 days with a loading dose of 200 mg on the first day. The control group received no treatment other than oral hygiene during the study. They were instructed to brush and floss 2 times a day. Clinical measurements were taken at each of the subsequent visits at the first, third, and sixth months. After obtaining the measurements and samples from the subjects, they were provided with professional supragingival plaque control measures, and oral hygiene was reinforced. This was repeated in the following recall visits.</offsets></p></sec><sec id="sec2-5"><title><offsets xml_i="19054" xml_f="19067" txt_i="11968" txt_f="11981">Data analysis</offsets></title><p><offsets xml_i="19078" xml_f="19254" txt_i="11982" txt_f="12158">All statistical analyses were carried out using the Statistical Package for Social Sciences for Windows, Version 17.0 (SPSS Inc., Chicago, IL, USA). The presence or absence of </offsets><italic><offsets xml_i="19262" xml_f="19272" txt_i="12158" txt_f="12168">Tf, Pg, Pi</offsets></italic><offsets xml_i="19281" xml_f="19287" txt_i="12168" txt_f="12174">, and </offsets><italic><offsets xml_i="19295" xml_f="19297" txt_i="12174" txt_f="12176">Aa</offsets></italic><offsets xml_i="19306" xml_f="19566" txt_i="12176" txt_f="12436"> were evaluated with McNemarâs test, and the results are presented in terms of the percentage of sites with the microorganisms. The results of dental parameters (PPD, CAL, GI, PI, and BOP) were analyzed using the 2-way analysis of variance (ANOVA). A value of </offsets><italic><offsets xml_i="19574" xml_f="19575" txt_i="12436" txt_f="12437">p</offsets></italic><offsets xml_i="19584" xml_f="19634" txt_i="12437" txt_f="12484">&lt;0.05 was considered statistically significant.</offsets></p></sec></sec><sec sec-type="results" id="sec1-6"><title><offsets xml_i="19693" xml_f="19700" txt_i="12487" txt_f="12494">Results</offsets></title><p><offsets xml_i="19711" xml_f="20013" txt_i="12495" txt_f="12797">Of the 76 subjects included in the study, 68 (33 CG and 35 TG) subjects completed the study. Most of the subjects (61.8%) were male, and the mean age of the participants was 42Â±6.41 years. On average, the subjects had 27 teeth in the oral cavity. The analysis of the periodontal parameters is shown in </offsets><xref ref-type="table" rid="T2"><bold><offsets xml_i="20051" xml_f="20058" txt_i="12797" txt_f="12804">Table 2</offsets></bold></xref><offsets xml_i="20072" xml_f="20098" txt_i="12804" txt_f="12830">. There were significant (</offsets><italic><offsets xml_i="20106" xml_f="20107" txt_i="12830" txt_f="12831">p</offsets></italic><offsets xml_i="20116" xml_f="20380" txt_i="12831" txt_f="13092">&lt;0.05) changes in PPD, PI, GI, and BOP for all the follow-up visits when compared with the baseline measurements. The PPD was reduced by 0.93 mm for the treatment and 0.88 mm for the control group in the reevaluation visit, which was statistically significant (</offsets><italic><offsets xml_i="20388" xml_f="20389" txt_i="13092" txt_f="13093">p</offsets></italic><offsets xml_i="20398" xml_f="20583" txt_i="13093" txt_f="13275">&lt;0.01). The CAL for CG was reduced by 0.84 mm during the reevaluation visit and by 0.96 mm from the baseline measurements by the end of 6 months. For TG, CAL was reduced by 0.39 mm (</offsets><italic><offsets xml_i="20591" xml_f="20592" txt_i="13275" txt_f="13276">p</offsets></italic><offsets xml_i="20601" xml_f="20986" txt_i="13276" txt_f="13661">=0.09) in the reevaluation visit and by 0.74 mm by the end of 6 months. However, no significant difference was observed between CG and TG in the reevaluation visit or during any of the remaining follow-up visits. Gingival index was the only parameter that showed any significant difference between TG and CG after one, 3, and 6 months after the administration of systemic doxycycline (</offsets><xref ref-type="table" rid="T2"><bold><offsets xml_i="21024" xml_f="21031" txt_i="13661" txt_f="13668">Table 2</offsets></bold></xref><offsets xml_i="21045" xml_f="21047" txt_i="13668" txt_f="13670">).</offsets></p><table-wrap id="T2" position="float"><label><offsets xml_i="21095" xml_f="21102" txt_i="13671" txt_f="13678">Table 2</offsets></label><caption><p><offsets xml_i="21122" xml_f="21257" txt_i="13678" txt_f="13813">Dental parameters of diabetic study subjects at baseline, re-evaluation, one, 3, and 6 months after administering systemic doxycycline.</offsets></p></caption><graphic xlink:href="SaudiMedJ-35-1203-g002"></graphic></table-wrap><p><offsets xml_i="21342" xml_f="21401" txt_i="13814" txt_f="13873">The results showing the effects of different treatments on </offsets><italic><offsets xml_i="21409" xml_f="21411" txt_i="13873" txt_f="13875">Tf</offsets></italic><offsets xml_i="21420" xml_f="21438" txt_i="13875" txt_f="13893"> are described in </offsets><xref ref-type="fig" rid="F1"><bold><offsets xml_i="21474" xml_f="21483" txt_i="13893" txt_f="13902">Figure 1A</offsets></bold></xref><offsets xml_i="21497" xml_f="21619" txt_i="13902" txt_f="14024">. In the first month after administering doxycycline, a significantly higher decline in the percentage of sites harboring </offsets><italic><offsets xml_i="21627" xml_f="21629" txt_i="14024" txt_f="14026">Tf</offsets></italic><offsets xml_i="21638" xml_f="21677" txt_i="14026" txt_f="14065"> was observed for TG compared with CG (</offsets><italic><offsets xml_i="21685" xml_f="21686" txt_i="14065" txt_f="14066">p</offsets></italic><offsets xml_i="21695" xml_f="21861" txt_i="14066" txt_f="14232">=0.02). However, a better reduction was observed in the CG as compared with the TG at the third-month visit, though this reduction was not statistically significant (</offsets><xref ref-type="table" rid="T3"><bold><offsets xml_i="21899" xml_f="21906" txt_i="14232" txt_f="14239">Table 3</offsets></bold></xref><offsets xml_i="21920" xml_f="21922" txt_i="14239" txt_f="14241">).</offsets></p><fig id="F1" position="float"><label><offsets xml_i="21963" xml_f="21971" txt_i="14242" txt_f="14250">Figure 1</offsets></label><caption><p><offsets xml_i="21991" xml_f="22020" txt_i="14250" txt_f="14279">Percentage of site harboring </offsets><bold><offsets xml_i="22026" xml_f="22027" txt_i="14279" txt_f="14280">A</offsets></bold><offsets xml_i="22034" xml_f="22036" txt_i="14280" txt_f="14282">) </offsets><italic><offsets xml_i="22044" xml_f="22069" txt_i="14282" txt_f="14307">Tannerella forsythia (Tf)</offsets></italic><offsets xml_i="22078" xml_f="22080" txt_i="14307" txt_f="14309">, </offsets><bold><offsets xml_i="22086" xml_f="22087" txt_i="14309" txt_f="14310">B</offsets></bold><offsets xml_i="22094" xml_f="22096" txt_i="14310" txt_f="14312">) </offsets><italic><offsets xml_i="22104" xml_f="22133" txt_i="14312" txt_f="14341">Porphyromonas gingivalis (Pg)</offsets></italic><offsets xml_i="22142" xml_f="22144" txt_i="14341" txt_f="14343">, </offsets><bold><offsets xml_i="22150" xml_f="22151" txt_i="14343" txt_f="14344">C</offsets></bold><offsets xml_i="22158" xml_f="22160" txt_i="14344" txt_f="14346">) </offsets><italic><offsets xml_i="22168" xml_f="22194" txt_i="14346" txt_f="14372">Prevotella intermedia (Pi)</offsets></italic><offsets xml_i="22203" xml_f="22209" txt_i="14372" txt_f="14378">, and </offsets><bold><offsets xml_i="22215" xml_f="22216" txt_i="14378" txt_f="14379">D</offsets></bold><offsets xml_i="22223" xml_f="22225" txt_i="14379" txt_f="14381">) </offsets><italic><offsets xml_i="22233" xml_f="22275" txt_i="14381" txt_f="14423">Aggregatibacter actinomycetemcomitans (Aa)</offsets></italic><offsets xml_i="22284" xml_f="22419" txt_i="14423" txt_f="14558"> as measured at the different time intervals among 76 diabetic patients with chronic periodontitis. CG - control group, TG - test group</offsets></p></caption><graphic xlink:href="SaudiMedJ-35-1203-g003"></graphic></fig><table-wrap id="T3" position="float"><label><offsets xml_i="22538" xml_f="22545" txt_i="14559" txt_f="14566">Table 3</offsets></label><caption><p><offsets xml_i="22565" xml_f="22755" txt_i="14566" txt_f="14756">Percentage reduction in sites harboring different species at each follow up visit compared to the values obtained in the previous visit among 76 diabetic patients with chronic periodontitis.</offsets></p></caption><graphic xlink:href="SaudiMedJ-35-1203-g004"></graphic></table-wrap><p><offsets xml_i="22840" xml_f="22898" txt_i="14757" txt_f="14815">The results showing the effect of systemic doxycycline on </offsets><italic><offsets xml_i="22906" xml_f="22908" txt_i="14815" txt_f="14817">Pg</offsets></italic><offsets xml_i="22917" xml_f="22922" txt_i="14817" txt_f="14822"> and </offsets><italic><offsets xml_i="22930" xml_f="22932" txt_i="14822" txt_f="14824">Pi</offsets></italic><offsets xml_i="22941" xml_f="22955" txt_i="14824" txt_f="14838"> are shown in </offsets><bold><offsets xml_i="22961" xml_f="22969" txt_i="14838" txt_f="14846">Figures </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="22999" xml_f="23001" txt_i="14846" txt_f="14848">1B</offsets></xref><offsets xml_i="23008" xml_f="23015" txt_i="14848" txt_f="14851"> &amp; </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="23045" xml_f="23047" txt_i="14851" txt_f="14853">1C</offsets></xref></bold><offsets xml_i="23061" xml_f="23119" txt_i="14853" txt_f="14911">. One month after the administration of doxycycline, both </offsets><italic><offsets xml_i="23127" xml_f="23129" txt_i="14911" txt_f="14913">Pg</offsets></italic><offsets xml_i="23138" xml_f="23144" txt_i="14913" txt_f="14919">, and </offsets><italic><offsets xml_i="23152" xml_f="23154" txt_i="14919" txt_f="14921">Pi</offsets></italic><offsets xml_i="23163" xml_f="23244" txt_i="14921" txt_f="15002"> showed significant reduction in the percentage of site for TG compared with CG (</offsets><italic><offsets xml_i="23252" xml_f="23253" txt_i="15002" txt_f="15003">p</offsets></italic><offsets xml_i="23262" xml_f="23275" txt_i="15003" txt_f="15013">&lt;0.01 and </offsets><italic><offsets xml_i="23283" xml_f="23284" txt_i="15013" txt_f="15014">p</offsets></italic><offsets xml_i="23293" xml_f="23485" txt_i="15014" txt_f="15206">=0.04). A minimal decline was observed in the following visits. There was no significant difference between CG and TG at different time points of the reduction in the percentage of sites with </offsets><italic><offsets xml_i="23493" xml_f="23495" txt_i="15206" txt_f="15208">Aa</offsets></italic><offsets xml_i="23504" xml_f="23506" txt_i="15208" txt_f="15210"> (</offsets><xref ref-type="fig" rid="F1"><bold><offsets xml_i="23542" xml_f="23551" txt_i="15210" txt_f="15219">Figure 1D</offsets></bold></xref><offsets xml_i="23565" xml_f="23684" txt_i="15219" txt_f="15338">). The percentage reductions in the sites harboring the different species at each of the follow-up visits are shown in </offsets><xref ref-type="table" rid="T3"><bold><offsets xml_i="23722" xml_f="23729" txt_i="15338" txt_f="15345">Table 3</offsets></bold></xref><offsets xml_i="23743" xml_f="23744" txt_i="15345" txt_f="15346">.</offsets></p></sec><sec sec-type="discussion" id="sec1-7"><title><offsets xml_i="23800" xml_f="23810" txt_i="15348" txt_f="15358">Discussion</offsets></title><p><offsets xml_i="23821" xml_f="23921" txt_i="15359" txt_f="15459">Periodontal disease involves complex interactions between microbial factors, and a susceptible host.</offsets><xref rid="ref25" ref-type="bibr"><offsets xml_i="23955" xml_f="23957" txt_i="15459" txt_f="15461">25</offsets></xref><offsets xml_i="23964" xml_f="24687" txt_i="15461" txt_f="16184"> One of the biological mechanisms reported is through the accumulation of glucose-mediated advanced glycation end products (AGEs), which leads to the impairment of the chemotactic and phagocytic functions of polymorphonuclear leukocytes. The bacterial products of the Gram-negative periodontopathic bacteria in periodontal pockets were found to increase the secretion of interleukin-1 beta (IL-1b), interleukin 6 (IL-6), tumor necrosis factor alpha (TNFa), and prostaglandin E2 (PGE2). The TNFa is a pro-inflammatory cytokine that has been implicated in insulin resistance. Adjunctive antimicrobial periodontal treatment has been reported to significantly reduce circulating TNFa and glycosylated hemoglobin (HbA1C) levels.</offsets><xref rid="ref26" ref-type="bibr"><offsets xml_i="24721" xml_f="24723" txt_i="16184" txt_f="16186">26</offsets></xref><offsets xml_i="24730" xml_f="24731" txt_i="16186" txt_f="16187">,</offsets><xref rid="ref27" ref-type="bibr"><offsets xml_i="24765" xml_f="24767" txt_i="16187" txt_f="16189">27</offsets></xref><offsets xml_i="24774" xml_f="24921" txt_i="16189" txt_f="16336"> Also, doxycycline at lower doses has been reported to reduce the periodontal tissue destruction by inhibiting collagenase activity and synsthesis.</offsets><xref rid="ref28" ref-type="bibr"><offsets xml_i="24955" xml_f="24957" txt_i="16336" txt_f="16338">28</offsets></xref><offsets xml_i="24964" xml_f="25061" txt_i="16338" txt_f="16435"> The reduction in HbA1c levels with the use of low dose doxycycline has been previously reported.</offsets><xref rid="ref29" ref-type="bibr"><offsets xml_i="25095" xml_f="25097" txt_i="16435" txt_f="16437">29</offsets></xref><offsets xml_i="25104" xml_f="25295" txt_i="16437" txt_f="16628"> In this study, the clinical and microbial effect of an antimicrobial regimen of systemic doxycycline on the periodontal tissues of diabetic patients with chronic periodontitis was evaluated.</offsets></p><p><offsets xml_i="25302" xml_f="25426" txt_i="16629" txt_f="16753">The occurrence of periodontal pathogens in subgingival flora in periodontitis is a risk for periodontal disease progression.</offsets><xref rid="ref30" ref-type="bibr"><offsets xml_i="25460" xml_f="25462" txt_i="16753" txt_f="16755">30</offsets></xref><offsets xml_i="25469" xml_f="25470" txt_i="16755" txt_f="16756">,</offsets><xref rid="ref31" ref-type="bibr"><offsets xml_i="25504" xml_f="25506" txt_i="16756" txt_f="16758">31</offsets></xref><offsets xml_i="25513" xml_f="25808" txt_i="16758" txt_f="17053"> Therefore, microbiological diagnostic procedures are justifiably indicated in the detection of pathogens as well as in monitoring of therapeutic success and result of the disease. Specific bacterial species are now considered to be vital in the initiation and progression of periodontitis, and </offsets><italic><offsets xml_i="25816" xml_f="25826" txt_i="17053" txt_f="17063">Aa, Pg, Tf</offsets></italic><offsets xml_i="25835" xml_f="25841" txt_i="17063" txt_f="17069">, and </offsets><italic><offsets xml_i="25849" xml_f="25851" txt_i="17069" txt_f="17071">Pi</offsets></italic><sup><offsets xml_i="25865" xml_f="25870" txt_i="17071" txt_f="17076">30,32</offsets></sup><offsets xml_i="25876" xml_f="26050" txt_i="17076" txt_f="17250"> are some of the more frequently encountered species. Doxycycline has been reported to substantially reduce or eliminate pathogenic species, especially Gram-negative bacilli.</offsets><xref rid="ref33" ref-type="bibr"><offsets xml_i="26084" xml_f="26086" txt_i="17250" txt_f="17252">33</offsets></xref><offsets xml_i="26093" xml_f="26109" txt_i="17252" txt_f="17268"> Several studies</offsets><xref rid="ref34" ref-type="bibr"><offsets xml_i="26143" xml_f="26145" txt_i="17268" txt_f="17270">34</offsets></xref><offsets xml_i="26152" xml_f="26239" txt_i="17270" txt_f="17357"> have reported that due to the tissue-invading nature of periodontal pathogens such as </offsets><italic><offsets xml_i="26247" xml_f="26249" txt_i="17357" txt_f="17359">Pg</offsets></italic><offsets xml_i="26258" xml_f="26263" txt_i="17359" txt_f="17364"> and </offsets><italic><offsets xml_i="26271" xml_f="26273" txt_i="17364" txt_f="17366">Aa</offsets></italic><offsets xml_i="26282" xml_f="26550" txt_i="17366" txt_f="17634">, mechanical therapy alone may not be sufficient to eliminate these pathogens. Hence, it may be useful to administer antibiotics that will help in eliminating these pathogens. In this study, the administration of systemic doxycycline was effective in the reduction of </offsets><italic><offsets xml_i="26558" xml_f="26564" txt_i="17634" txt_f="17640">Tf, Pi</offsets></italic><offsets xml_i="26573" xml_f="26579" txt_i="17640" txt_f="17646">, and </offsets><italic><offsets xml_i="26587" xml_f="26589" txt_i="17646" txt_f="17648">Pg</offsets></italic><offsets xml_i="26598" xml_f="26707" txt_i="17648" txt_f="17757">. The greatest reduction in the percentage of sites after the administration of doxycycline was observed for </offsets><italic><offsets xml_i="26715" xml_f="26717" txt_i="17757" txt_f="17759">Pg</offsets></italic><offsets xml_i="26726" xml_f="26809" txt_i="17759" txt_f="17842">. This finding is agreeing with results from a previous study performed on smokers.</offsets><xref rid="ref12" ref-type="bibr"><offsets xml_i="26843" xml_f="26845" txt_i="17842" txt_f="17844">12</offsets></xref><offsets xml_i="26852" xml_f="26853" txt_i="17844" txt_f="17845">
</offsets><italic><offsets xml_i="26861" xml_f="26885" txt_i="17845" txt_f="17869">Porphyromonas gingivalis</offsets></italic><offsets xml_i="26894" xml_f="27032" txt_i="17869" txt_f="18007"> induces a local chronic inflammatory response that results in oral inflammatory bone destruction, which manifests as periodontal disease.</offsets><xref rid="ref35" ref-type="bibr"><offsets xml_i="27066" xml_f="27068" txt_i="18007" txt_f="18009">35</offsets></xref></p><p><offsets xml_i="27082" xml_f="27097" txt_i="18010" txt_f="18025">Eradication of </offsets><italic><offsets xml_i="27105" xml_f="27107" txt_i="18025" txt_f="18027">Aa</offsets></italic><offsets xml_i="27116" xml_f="27203" txt_i="18027" txt_f="18114"> from deep periodontal pockets could be difficult. It is reported that the decrease in </offsets><italic><offsets xml_i="27211" xml_f="27213" txt_i="18114" txt_f="18116">Aa</offsets></italic><offsets xml_i="27222" xml_f="27286" txt_i="18116" txt_f="18180"> is often not as great as that for other bacteria following SRP.</offsets><xref rid="ref36" ref-type="bibr"><offsets xml_i="27320" xml_f="27322" txt_i="18180" txt_f="18182">36</offsets></xref><offsets xml_i="27329" xml_f="27354" txt_i="18182" txt_f="18207"> A study by Muller et al,</offsets><xref rid="ref37" ref-type="bibr"><offsets xml_i="27388" xml_f="27390" txt_i="18207" txt_f="18209">37</offsets></xref><offsets xml_i="27397" xml_f="27412" txt_i="18209" txt_f="18224"> reported that </offsets><italic><offsets xml_i="27420" xml_f="27422" txt_i="18224" txt_f="18226">Aa</offsets></italic><offsets xml_i="27431" xml_f="27579" txt_i="18226" txt_f="18374"> at subgingival and extra-crevicular sites are suppressed with the use of adjunct antimicrobial therapy. Similarly, in this study, the reduction of </offsets><italic><offsets xml_i="27587" xml_f="27589" txt_i="18374" txt_f="18376">Aa</offsets></italic><offsets xml_i="27598" xml_f="27704" txt_i="18376" txt_f="18482"> was observed, although it was less than that observed with other pathogens. Additionally, in the case of </offsets><italic><offsets xml_i="27712" xml_f="27714" txt_i="18482" txt_f="18484">Aa</offsets></italic><offsets xml_i="27723" xml_f="27728" txt_i="18484" txt_f="18489"> and </offsets><italic><offsets xml_i="27736" xml_f="27738" txt_i="18489" txt_f="18491">Tf</offsets></italic><offsets xml_i="27747" xml_f="27866" txt_i="18491" txt_f="18610">, there was a slight increase in the percentage of sites after 3 months. This is similar to the study by Colombo et al,</offsets><xref rid="ref38" ref-type="bibr"><offsets xml_i="27900" xml_f="27902" txt_i="18610" txt_f="18612">38</offsets></xref><offsets xml_i="27909" xml_f="27933" txt_i="18612" txt_f="18636"> where the frequency of </offsets><italic><offsets xml_i="27941" xml_f="27943" txt_i="18636" txt_f="18638">Aa</offsets></italic><offsets xml_i="27952" xml_f="28576" txt_i="18638" txt_f="19262"> increased after therapy, probably due to an absence of antibiotic protection. Compared with the baseline measurements, all the clinical parameters in both, the CG and TG had significantly improved at the reevaluation visit during the follow up visits. However, with exception to GI, no other clinical parameters showed a significant difference between the CG and TG. The GI significantly improved with the administration of adjunct systemic doxycycline. This could be due to the inhibitory effect of doxycycline that significantly reduces the periodontal tissue destruction by inhibiting collagenase activity and synthesis.</offsets><xref rid="ref28" ref-type="bibr"><offsets xml_i="28610" xml_f="28612" txt_i="19262" txt_f="19264">28</offsets></xref><offsets xml_i="28619" xml_f="28641" txt_i="19264" txt_f="19286"> Many previous studies</offsets><xref rid="ref28" ref-type="bibr"><offsets xml_i="28675" xml_f="28677" txt_i="19286" txt_f="19288">28</offsets></xref><offsets xml_i="28684" xml_f="28685" txt_i="19288" txt_f="19289">,</offsets><xref rid="ref39" ref-type="bibr"><offsets xml_i="28719" xml_f="28721" txt_i="19289" txt_f="19291">39</offsets></xref><offsets xml_i="28728" xml_f="28964" txt_i="19291" txt_f="19527"> administered adjunctive antimicrobial agent along with SRP. However, to understand the effectiveness of an antimicrobial drug, it should be introduced after SRP; however, only microorganisms that were resistant to SRP would be present.</offsets><xref rid="ref40" ref-type="bibr"><offsets xml_i="28998" xml_f="29000" txt_i="19527" txt_f="19529">40</offsets></xref><offsets xml_i="29007" xml_f="29065" txt_i="19529" txt_f="19587"> Also, it is well known that the number and percentage of </offsets><italic><offsets xml_i="29073" xml_f="29079" txt_i="19587" txt_f="19593">Tf, Pg</offsets></italic><offsets xml_i="29088" xml_f="29094" txt_i="19593" txt_f="19599">, and </offsets><italic><offsets xml_i="29102" xml_f="29104" txt_i="19599" txt_f="19601">Pi</offsets></italic><offsets xml_i="29113" xml_f="29178" txt_i="19601" txt_f="19666"> decrease with decreasing pocket depth with or without treatment.</offsets><xref rid="ref41" ref-type="bibr"><offsets xml_i="29212" xml_f="29214" txt_i="19666" txt_f="19668">41</offsets></xref><offsets xml_i="29221" xml_f="29438" txt_i="19668" txt_f="19885"> Therefore, it would not be possible to state conclusively the role of the antibiotic in the reduction of the microbial population. Hence, during the reevaluation visit, doxycycline was administered 45 days after SRP.</offsets></p><sec id="sec2-6"><title><offsets xml_i="29466" xml_f="29483" txt_i="19886" txt_f="19903">Study limitations</offsets></title><p><offsets xml_i="29494" xml_f="29695" txt_i="19904" txt_f="20105">The major limitation of this study was the limited number of patients and limited number of bacteria examined. Further research is needed to support a causal relationship and its clinical implications.</offsets></p><p><offsets xml_i="29702" xml_f="29756" txt_i="20106" txt_f="20160">In conclusion, the TG showed significant reduction of </offsets><italic><offsets xml_i="29764" xml_f="29766" txt_i="20160" txt_f="20162">Tf</offsets></italic><offsets xml_i="29775" xml_f="29777" txt_i="20162" txt_f="20164">, </offsets><italic><offsets xml_i="29785" xml_f="29787" txt_i="20164" txt_f="20166">Pg</offsets></italic><offsets xml_i="29796" xml_f="29802" txt_i="20166" txt_f="20172">, and </offsets><italic><offsets xml_i="29810" xml_f="29812" txt_i="20172" txt_f="20174">Pi</offsets></italic><offsets xml_i="29821" xml_f="30284" txt_i="20174" txt_f="20637"> in the first month after the administration of systemic doxycycline. However, this did not improve the periodontal status of the subjects. There were minimal differences between CG and TG at the 3 and 6-month follow-up visits. Additional long-term studies with larger sample sizes are required to provide a more comprehensive picture of the effects of SRP and systemic doxycycline at clinical and microbial levels in diabetic patients with chronic periodontitis.</offsets></p></sec></sec></body><back><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanko</surname><given-names>P</given-names></name><name><surname>Izakovicova</surname><given-names>Holla L</given-names></name></person-group><article-title>Bidirectional association between diabetes mellitus and inflammatory periodontal disease. A review</article-title><source>Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub</source><year>2014</year><volume>158</volume><fpage>35</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">24509898</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iacopino</surname><given-names>AM</given-names></name></person-group><article-title>Periodontitis and diabetes interrelationships: role of inflammation</article-title><source>Ann Periodontol</source><year>2001</year><volume>6</volume><fpage>125</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">11887455</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sima</surname><given-names>C</given-names></name><name><surname>Rhourida</surname><given-names>K</given-names></name><name><surname>Van Dyke</surname><given-names>TE</given-names></name><name><surname>Gyurko</surname><given-names>R</given-names></name></person-group><article-title>Type 1. diabetes predisposes to enhanced gingival leukocyte margination and macromolecule extravasation <italic>in vivo</italic></article-title><source>J Periodontal Res</source><year>2010</year><volume>45</volume><fpage>748</fpage><lpage>756</lpage><pub-id pub-id-type="pmid">20682016</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>KÄ±ran</surname><given-names>M</given-names></name><name><surname>Arpak</surname><given-names>N</given-names></name><name><surname>Ãnsal</surname><given-names>E</given-names></name><name><surname>ErdoÄan</surname><given-names>MF</given-names></name></person-group><article-title>The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus</article-title><source>J Clin Periodontol</source><year>2005</year><volume>32</volume><fpage>266</fpage><lpage>272</lpage><pub-id pub-id-type="pmid">15766369</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kesic</surname><given-names>L</given-names></name><name><surname>Petrovic</surname><given-names>D</given-names></name><name><surname>Obradovic</surname><given-names>R</given-names></name><name><surname>Gasic</surname><given-names>J</given-names></name><name><surname>Todorovic</surname><given-names>K</given-names></name></person-group><article-title>Diabetes mellitus and periodontal disease</article-title><source>Med Pregl</source><year>2009</year><volume>62</volume><fpage>534</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">20491379</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cullinan</surname><given-names>M</given-names></name><name><surname>Ford</surname><given-names>P</given-names></name><name><surname>Seymour</surname><given-names>G</given-names></name></person-group><article-title>Periodontal disease and systemic health: current status</article-title><source>Aust Dent J</source><year>2009</year><volume>54</volume><issue>Suppl 1</issue><fpage>S62</fpage><lpage>S69</lpage><pub-id pub-id-type="pmid">19737269</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LÃ¶e</surname><given-names>H</given-names></name></person-group><article-title>Periodontal disease. The sixth complication of diabetes mellitus</article-title><source>Diabetes Care</source><year>1993</year><volume>16</volume><fpage>329</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">8422804</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mealey</surname><given-names>BL</given-names></name><name><surname>Oates</surname><given-names>TW</given-names></name></person-group><article-title>Diabetes mellitus and periodontal diseases</article-title><source>J Periodontol</source><year>2006</year><volume>77</volume><fpage>1289</fpage><lpage>1303</lpage><pub-id pub-id-type="pmid">16881798</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Khabbaz</surname><given-names>AK</given-names></name></person-group><article-title>Type 2 diabetes mellitus and periodontal disease severity</article-title><source>Oral Health Prev Dent</source><year>2014</year><volume>12</volume><fpage>77</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">24619786</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuramitsu</surname><given-names>HK</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Lux</surname><given-names>R</given-names></name><name><surname>Anderson</surname><given-names>MH</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group><article-title>Interspecies interactions within oral microbial communities</article-title><source>Microbiol Mol Biol Rev</source><year>2007</year><volume>71</volume><fpage>653</fpage><lpage>670</lpage><pub-id pub-id-type="pmid">18063722</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunner</surname><given-names>J</given-names></name><name><surname>Scheres</surname><given-names>N</given-names></name><name><surname>El Idrissi</surname><given-names>NB</given-names></name><name><surname>Deng</surname><given-names>DM</given-names></name><name><surname>Laine</surname><given-names>ML</given-names></name><name><surname>van Winkelhoff</surname><given-names>AJ</given-names></name><etal></etal></person-group><article-title>The capsule of <italic>Porphyromonas gingivalis</italic> reduces the immune response of human gingival fibroblasts</article-title><source>BMC Microbiol</source><year>2010</year><volume>10</volume><fpage>5</fpage><pub-id pub-id-type="pmid">20064245</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaddox</surname><given-names>L</given-names></name><name><surname>Andia</surname><given-names>DC</given-names></name><name><surname>Casati</surname><given-names>MZ</given-names></name><name><surname>Nociti</surname><given-names>FH</given-names><suffix>Jr</suffix></name><name><surname>Sallum</surname><given-names>EA</given-names></name><name><surname>Gollwitzer</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Microbiologic changes following administration of locally delivered doxycycline in smokers: a 15-month follow-up</article-title><source>J Periodontol</source><year>2007</year><volume>78</volume><fpage>2143</fpage><lpage>2149</lpage><pub-id pub-id-type="pmid">17970681</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siqueira</surname><given-names>JF</given-names><suffix>Jr</suffix></name><name><surname>RÃ´Ã§as</surname><given-names>IN</given-names></name></person-group><article-title>Bacterial pathogenesis and mediators in apical periodontitis</article-title><source>Braz Dent J</source><year>2007</year><volume>18</volume><fpage>267</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">18278296</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gay</surname><given-names>IC</given-names></name><name><surname>Tran</surname><given-names>DT</given-names></name><name><surname>Cavender</surname><given-names>AC</given-names></name><name><surname>Weltman</surname><given-names>R</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name><name><surname>Luckenbach</surname><given-names>E</given-names></name><etal></etal></person-group><article-title>The effect of periodontal therapy on glycaemic control in a Hispanic population with type 2. diabetes: a randomized controlled trial</article-title><source>J Clin Periodontol</source><year>2014</year><volume>41</volume><fpage>673</fpage><lpage>680</lpage><pub-id pub-id-type="pmid">24797222</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sgolastra</surname><given-names>F</given-names></name><name><surname>Severino</surname><given-names>M</given-names></name><name><surname>Petrucci</surname><given-names>A</given-names></name><name><surname>Gatto</surname><given-names>R</given-names></name><name><surname>Monaco</surname><given-names>A</given-names></name></person-group><article-title>Effectiveness of metronidazole as an adjunct to scaling and root planing in the treatment of chronic periodontitis: a systematic review and meta-analysis</article-title><source>J Periodontal Res</source><year>2014</year><volume>49</volume><fpage>10</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">23668676</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winkel</surname><given-names>EG</given-names></name><name><surname>Van Winkelhoff</surname><given-names>AJ</given-names></name><name><surname>Timmerman</surname><given-names>MF</given-names></name><name><surname>Van der Velden</surname><given-names>U</given-names></name><name><surname>Van der Weijden</surname><given-names>GA</given-names></name></person-group><article-title>Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo-controlled study</article-title><source>J Clin Periodontol</source><year>2001</year><volume>28</volume><fpage>296</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">11314884</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehmke</surname><given-names>B</given-names></name><name><surname>Moter</surname><given-names>A</given-names></name><name><surname>Beikler</surname><given-names>T</given-names></name><name><surname>Milian</surname><given-names>E</given-names></name><name><surname>Flemmig</surname><given-names>TF</given-names></name></person-group><article-title>Adjunctive antimicrobial therapy of periodontitis: long-term effects on disease progression and oral colonization</article-title><source>J Periodontol</source><year>2005</year><volume>76</volume><fpage>749</fpage><lpage>759</lpage><pub-id pub-id-type="pmid">15898936</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caton</surname><given-names>JG</given-names></name><name><surname>Ciancio</surname><given-names>SG</given-names></name><name><surname>Blieden</surname><given-names>TM</given-names></name><name><surname>Bradshaw</surname><given-names>M</given-names></name><name><surname>Crout</surname><given-names>RJ</given-names></name><name><surname>Hefti</surname><given-names>AF</given-names></name><etal></etal></person-group><article-title>Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis</article-title><source>J Periodontol</source><year>2000</year><volume>71</volume><fpage>521</fpage><lpage>532</lpage><pub-id pub-id-type="pmid">10807113</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanes</surname><given-names>PJ</given-names></name><name><surname>Purvis</surname><given-names>JP</given-names></name></person-group><article-title>Local anti-infective therapy: pharmacological agents. A systematic review</article-title><source>Ann Periodontol</source><year>2003</year><volume>8</volume><fpage>79</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">14971250</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>AS</given-names></name><name><surname>LourenÃ§Ã£o</surname><given-names>DS</given-names></name><name><surname>Lima Neto</surname><given-names>LG</given-names></name><name><surname>Pannuti</surname><given-names>CM</given-names></name><name><surname>Hirata</surname><given-names>RD</given-names></name><name><surname>Hirata</surname><given-names>MH</given-names></name><etal></etal></person-group><article-title>Clinical and microbiological evaluation, by real-time PCR of non-surgical treatment of aggressive periodontitis associated with amoxicillin and metronidazole</article-title><source>J Periodontol</source><year>2012</year><volume>83</volume><fpage>744</fpage><lpage>752</lpage><pub-id pub-id-type="pmid">22060046</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerrero</surname><given-names>A</given-names></name><name><surname>Griffiths</surname><given-names>GS</given-names></name><name><surname>Nibali</surname><given-names>L</given-names></name><name><surname>Suvan</surname><given-names>J</given-names></name><name><surname>Moles</surname><given-names>DR</given-names></name><name><surname>Laurell</surname><given-names>L</given-names></name><etal></etal></person-group><article-title>Adjunctive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: a randomized placebo-controlled clinical trial</article-title><source>J Clin Periodontol</source><year>2005</year><volume>32</volume><fpage>1096</fpage><lpage>1107</lpage><pub-id pub-id-type="pmid">16174275</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xajigeorgiou</surname><given-names>C</given-names></name><name><surname>Sakellari</surname><given-names>D</given-names></name><name><surname>Slini</surname><given-names>T</given-names></name><name><surname>Baka</surname><given-names>A</given-names></name><name><surname>Konstantinidis</surname><given-names>A</given-names></name></person-group><article-title>Clinical and microbiological effects of different antimicrobials on generalized aggressive periodontitis</article-title><source>J Clin Periodontol</source><year>2006</year><volume>33</volume><fpage>254</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">16553634</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darby</surname><given-names>IB</given-names></name><name><surname>Hodge</surname><given-names>PJ</given-names></name><name><surname>Riggio</surname><given-names>MP</given-names></name><name><surname>Kinane</surname><given-names>DF</given-names></name></person-group><article-title>Clinical and microbiological effect of scaling and root planing in smoker and non-smoker chronic and aggressive periodontitis patients</article-title><source>J Clin Periodontol</source><year>2005</year><volume>32</volume><fpage>200</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">15691352</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armitage</surname><given-names>GC</given-names></name></person-group><article-title>Periodontal diagnoses and classification of periodontal diseases</article-title><source>Periodontol 2000</source><year>2004</year><volume>34</volume><fpage>9</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">14717852</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>RJ</given-names><suffix>Jr</suffix></name></person-group><article-title>Composition and development of oral bacterial communities</article-title><source>Periodontol 2000</source><year>2014</year><volume>64</volume><fpage>20</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">24320954</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grossi</surname><given-names>SG</given-names></name><name><surname>Skrepcinski</surname><given-names>FB</given-names></name><name><surname>DeCaro</surname><given-names>T</given-names></name><name><surname>Robertson</surname><given-names>DC</given-names></name><name><surname>Ho</surname><given-names>AW</given-names></name><name><surname>Dunford</surname><given-names>RG</given-names></name><etal></etal></person-group><article-title>Treatment of periodontal disease in diabetics reduces glycated hemoglobin</article-title><source>J Periodontol</source><year>1997</year><volume>68</volume><fpage>713</fpage><lpage>739</lpage><pub-id pub-id-type="pmid">9287060</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwamoto</surname><given-names>Y</given-names></name><name><surname>Nishimura</surname><given-names>F</given-names></name><name><surname>Nakagawa</surname><given-names>M</given-names></name><name><surname>Sugimoto</surname><given-names>H</given-names></name><name><surname>Shikata</surname><given-names>K</given-names></name><name><surname>Makino</surname><given-names>H</given-names></name><etal></etal></person-group><article-title>The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes</article-title><source>J Periodontol</source><year>2001</year><volume>72</volume><fpage>774</fpage><lpage>778</lpage><pub-id pub-id-type="pmid">11453240</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Promsudthi</surname><given-names>A</given-names></name><name><surname>Pimapansri</surname><given-names>S</given-names></name><name><surname>Deerochanawong</surname><given-names>C</given-names></name><name><surname>Kanchanavasita</surname><given-names>W</given-names></name></person-group><article-title>The effect of periodontal therapy on uncontrolled type 2 diabetes mellitus in older subjects</article-title><source>Oral Diseases</source><year>2005</year><volume>11</volume><fpage>293</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">16120115</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Mubarak</surname><given-names>S</given-names></name><name><surname>Abou</surname><given-names>Rass M</given-names></name><name><surname>Alsuwyed</surname><given-names>A</given-names></name><name><surname>Al-Zoman</surname><given-names>K</given-names></name><name><surname>Al Sohail</surname><given-names>A</given-names></name><name><surname>Sobki</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>A new paradigm between mechanical scaling and root planing combined with adjunctive chemotherapy for glycated hemoglobin improvement in diabetics</article-title><source>International Journal of Diabetes Mellitus</source><year>2010</year><volume>2</volume><fpage>158</fpage><lpage>164</lpage></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riep</surname><given-names>B</given-names></name><name><surname>Edesi-Neuss</surname><given-names>L</given-names></name><name><surname>Claessen</surname><given-names>F</given-names></name><name><surname>Skarabis</surname><given-names>H</given-names></name><name><surname>Ehmke</surname><given-names>B</given-names></name><name><surname>Flemmig</surname><given-names>TF</given-names></name><etal></etal></person-group><article-title>Are putative periodontal pathogens reliable diagnostic markers?</article-title><source>J Clin Microbiol</source><year>2009</year><volume>47</volume><fpage>1705</fpage><lpage>1711</lpage><pub-id pub-id-type="pmid">19386852</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torrungruang</surname><given-names>K</given-names></name><name><surname>Bandhaya</surname><given-names>P</given-names></name><name><surname>Likittanasombat</surname><given-names>K</given-names></name><name><surname>Grittayaphong</surname><given-names>C</given-names></name></person-group><article-title>Relationship between the presence of certain bacterial pathogens and periodontal status of urban Thai adults</article-title><source>J Periodontol</source><year>2009</year><volume>80</volume><fpage>122</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">19228098</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Winkelhoff</surname><given-names>A</given-names></name><name><surname>Loos</surname><given-names>B</given-names></name><name><surname>Van Der</surname><given-names>Reijden W</given-names></name><name><surname>Van Der</surname><given-names>Velden U</given-names></name></person-group><article-title>Porphyromonas gingivalis, Bacteroides forsythus and other putative periodontal pathogens in subjects with and without periodontal destruction</article-title><source>J Clin Periodontol</source><year>2002</year><volume>29</volume><fpage>1023</fpage><lpage>1028</lpage><pub-id pub-id-type="pmid">12472995</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>SK</given-names></name><name><surname>Setty</surname><given-names>S</given-names></name><name><surname>Acharya</surname><given-names>AB</given-names></name><name><surname>Thakur</surname><given-names>SL</given-names></name></person-group><article-title>Efficacy of locally-delivered doxycycline microspheres in chronic localized periodontitis and on Porphyromonas gingivalis</article-title><source>J Investig Clin Dent</source><year>2012</year><volume>3</volume><fpage>128</fpage><lpage>134</lpage></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambrosini</surname><given-names>P</given-names></name><name><surname>Miller</surname><given-names>N</given-names></name><name><surname>BrianÃ§on</surname><given-names>S</given-names></name><name><surname>Gallina</surname><given-names>S</given-names></name><name><surname>Penaud</surname><given-names>J</given-names></name></person-group><article-title>Clinical and microbiological evaluation of the effectiveness of the Nd: Yap laser for the initial treatment of adult periodontitis</article-title><source>J Clin Periodontol</source><year>2005</year><volume>32</volume><fpage>670</fpage><lpage>676</lpage><pub-id pub-id-type="pmid">15882229</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>C</given-names></name><name><surname>Gudino</surname><given-names>CV</given-names></name><name><surname>Gibson</surname><given-names>FC</given-names><suffix>3rd</suffix></name><name><surname>Genco</surname><given-names>CA</given-names></name></person-group><article-title>Review: Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways</article-title><source>Mol Oral Microbiol</source><year>2010</year><volume>25</volume><fpage>305</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">20883220</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renvert</surname><given-names>S</given-names></name><name><surname>WikstrÃ¶m</surname><given-names>M</given-names></name><name><surname>DahlÃ©n</surname><given-names>G</given-names></name><name><surname>Slots</surname><given-names>J</given-names></name><name><surname>Egelberg</surname><given-names>J</given-names></name></person-group><article-title>On the inability of root debridement and periodontal surgery to eliminate <italic>Actinobacillus actinomycetemcomitans</italic> from periodontal pockets</article-title><source>J Clin Periodontol</source><year>1990</year><volume>17</volume><fpage>351</fpage><lpage>355</lpage><pub-id pub-id-type="pmid">2398131</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MÃ¼ller</surname><given-names>HP</given-names></name><name><surname>Heinecke</surname><given-names>A</given-names></name><name><surname>Borneff</surname><given-names>M</given-names></name><name><surname>Kiencke</surname><given-names>C</given-names></name><name><surname>Knopf</surname><given-names>A</given-names></name><name><surname>Pohl</surname><given-names>S</given-names></name></person-group><article-title>Eradication of Actinobacillus actinomycetemcomitans from the oral cavity in adult periodontitis</article-title><source>J Periodontal Res</source><year>1998</year><volume>33</volume><fpage>49</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">9524321</pub-id></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colombo</surname><given-names>AP</given-names></name><name><surname>Teles</surname><given-names>RP</given-names></name><name><surname>Torres</surname><given-names>MC</given-names></name><name><surname>RosalÃ©m</surname><given-names>W</given-names></name><name><surname>Mendes</surname><given-names>MC</given-names></name><name><surname>Souto</surname><given-names>RM</given-names></name><etal></etal></person-group><article-title>Effects of non-surgical mechanical therapy on the subgingival microbiota of Brazilians with untreated chronic periodontitis: 9-month results</article-title><source>J Periodontol</source><year>2005</year><volume>76</volume><fpage>778</fpage><lpage>784</lpage><pub-id pub-id-type="pmid">15898939</pub-id></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaner</surname><given-names>D</given-names></name><name><surname>Christan</surname><given-names>C</given-names></name><name><surname>Dietrich</surname><given-names>T</given-names></name><name><surname>Bernimoulin</surname><given-names>JP</given-names></name><name><surname>Kleber</surname><given-names>BM</given-names></name><name><surname>Friedmann</surname><given-names>A</given-names></name></person-group><article-title>Timing affects the clinical outcome of adjunctive systemic antibiotic therapy for generalized aggressive periodontitis</article-title><source>J Periodontol</source><year>2007</year><volume>78</volume><fpage>1201</fpage><lpage>1208</lpage><pub-id pub-id-type="pmid">17608574</pub-id></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Socransky</surname><given-names>SS</given-names></name><name><surname>Haffajee</surname><given-names>AD</given-names></name></person-group><article-title>Dental biofilms: difficult therapeutic targets</article-title><source>Periodontol 2000</source><year>2002</year><volume>28</volume><fpage>12</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">12013340</pub-id></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haffajee</surname><given-names>AD</given-names></name><name><surname>Teles</surname><given-names>RP</given-names></name><name><surname>Socransky</surname><given-names>SS</given-names></name></person-group><article-title>The effect of periodontal therapy on the composition of the subgingival microbiota</article-title><source>Periodontology 2000</source><year>2006</year><volume>42</volume><fpage>219</fpage><lpage>258</lpage><pub-id pub-id-type="pmid">16930312</pub-id></element-citation></ref></ref-list></back></article>